PhRMA's comments in response to the Institute for Clinical and Economic Review's (ICER) open call for stakeholder feedback on how it can improve its value assessment framework. As a voluntary, non-profit organization representing the nation's leading research-based pharmaceutical and biotechnology companies, PhRMA is also a long-standing supporter of evidence to support health care decision-making, including value assessment frameworks.